Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hyams

Showing results (311-320 of 366) with videos related to

Pageof 37
Sort By:
Hepatology Communications|November 9, 2020
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver DiseaseSimon Lam, Ruchi Singh, Jonathan R Dillman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2023
Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score NormalizationDuke Geem, David Hercules, Ranjit S Pelia, et al.
Inflammatory Bowel Diseases|April 27, 2021
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative ColitisJeffrey S Hyams, Michael Brimacombe, Yael Haberman, et al.
Inflammatory Bowel Diseases|November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's diseaseDavid J Keljo, James Markowitz, Christine Langton, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and AdolescentsNicholas M Croft, Lissy de Ridder, Anne M Griffiths, et al.
The American Journal of Gastroenterology|January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyJeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's DiseaseVictoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Gastroenterology|February 15, 2017
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel DiseaseJeffrey S Hyams, Marla C Dubinsky, Robert N Baldassano, et al.
Nature Protocols|April 3, 2020
Cloning of ground-state intestinal stem cells from endoscopic biopsy samplesMarcin Duleba, Yusuke Yamamoto, Rahul Neupane, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Environmental TriggersShuk-Mei Ho, James D Lewis, Emeran A Mayer, et al.
Pageof 37

Showing results (311-320 of 366) with videos related to

Sort By:
Pageof 37
Hepatology Communications|November 9, 2020
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver DiseaseSimon Lam, Ruchi Singh, Jonathan R Dillman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2023
Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score NormalizationDuke Geem, David Hercules, Ranjit S Pelia, et al.
Inflammatory Bowel Diseases|April 27, 2021
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative ColitisJeffrey S Hyams, Michael Brimacombe, Yael Haberman, et al.
Inflammatory Bowel Diseases|November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's diseaseDavid J Keljo, James Markowitz, Christine Langton, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and AdolescentsNicholas M Croft, Lissy de Ridder, Anne M Griffiths, et al.
The American Journal of Gastroenterology|January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyJeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's DiseaseVictoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Gastroenterology|February 15, 2017
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel DiseaseJeffrey S Hyams, Marla C Dubinsky, Robert N Baldassano, et al.
Nature Protocols|April 3, 2020
Cloning of ground-state intestinal stem cells from endoscopic biopsy samplesMarcin Duleba, Yusuke Yamamoto, Rahul Neupane, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Environmental TriggersShuk-Mei Ho, James D Lewis, Emeran A Mayer, et al.
Pageof 37